Cargando…
Percutaneous microwave ablation combined with simultaneous transarterial chemoembolization for hepatocellular carcinoma with macrovascular invasion or extrahepatic metastases
OBJECTIVE: To evaluate the safety and efficacy of percutaneous microwave ablation (MWA) combined with simultaneous transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC) patients with microvascular invasion (MVI) or extrahepatic metastases (EHM). METHODS: Between Augu...
Autores principales: | Wu, Mengfei, Gao, Shanshan, Song, Huadan, Zhang, Zihan, Zheng, Zhiyuan, Yan, Zhiping, Wang, Xiaolin, Wang, Jianhua, Liu, Lingxiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562208/ https://www.ncbi.nlm.nih.gov/pubmed/34805873 http://dx.doi.org/10.1016/j.jimed.2019.07.003 |
Ejemplares similares
-
Hepatocellular Carcinoma with Radiological Progression: Lenvatinib Plus PD-1 Inhibitor Combined with Microwave Ablation and Synchronous Transarterial Chemoembolization
por: Shi, Qin, et al.
Publicado: (2023) -
Microwave ablation combined with transarterial chemoembolization containing doxorubicin hydrochloride liposome for treating primary and metastatic liver cancers
por: Shi, Qin, et al.
Publicado: (2023) -
Transarterial chemoembolization for advanced hepatocellular carcinoma without macrovascular invasion or extrahepatic metastasis: analysis of factors prognostic of clinical outcomes
por: Kim, Ji Hoon, et al.
Publicado: (2023) -
Microwave ablation and synchronous transarterial chemoembolization combined with PD-1 inhibitor in patients with hepatocellular carcinoma following tyrosine kinase inhibitor intolerance
por: Shi, Qin, et al.
Publicado: (2023) -
Percutaneous microwave ablation combined with simultaneous transarterial chemoembolization for the treatment of advanced intrahepatic cholangiocarcinoma
por: Yang, Guo-Wei, et al.
Publicado: (2015)